Venrock Adviser, LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Venrock Adviser, LLC reported 38 stock positions worth $1.9 billion. Its top holding was Apogee Therapeutics (APGE) at 26.1% of the portfolio, followed by Ocular Therapeutix (OCUL, 5.8%) and Enliven Therapeutics (ELVN, 5.4%). Compared with Q2 2024, it opened 4 new positions, sold out of 1, added to 5 and reduced 6. The biggest buy was a new position in Oruka Therapeutics (ORKA) and the biggest sale Merus (MRUS, shares −28%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001615982
Portfolio Value
$1.9B (Q3 2024)
SEC Filing
0001104659-24-118950 ↗ filed Nov 14, 2024

Holdings Value

0$1.0B$2.0B$3.0B$4.0B Q1 2024: $2.1B Q1 2024 Q2 2024: $1.6B Q2 2024 Q3 2024: $1.9B $1.9B Q3 2024 Q4 2024: $1.5B Q4 2024 Q1 2025: $1.2B Q1 2025 Q2 2025: $1.3B Q2 2025 Q3 2025: $1.8B Q3 2025 Q4 2025: $2.0B Q4 2025 Q1 2026: $2.7B Q1 2026 Q2 2026: $3.3B Q2 2026

Holdings 38 stocks · $1.9B

APGE Apogee Therapeutics Inc. 26.13% 8,493,321 $498.9M No change
OCUL Ocular Therapeutix Inc. 5.82% 12,762,462 $111.0M No change
ELVN Enliven Therapeutics Inc. 5.39% 4,026,331 $102.8M No change
VRDN Viridian Therapeutics Inc. 4.63% 3,882,709 $88.3M Add +0.0%
APLT Applied Therapeutics Inc. 4.37% 9,825,000 $83.5M Add +3.0%
SYRE Spyre Therapeutics Inc. 4.14% 2,685,448 $79.0M No change
DYN Dyne Therapeutics Inc. 4.09% 2,173,913 $78.1M No change
ORKA Oruka Therapeutics Inc. 3.96% 3,085,620 $75.6M New
KALV Kalvista Pharmaceuticals Inc. 3.79% 6,249,731 $72.4M No change
PHVS Pharvaris NV 3.29% 3,395,606 $62.9M No change
COGT Cogent Biosciences Inc. 3.22% 5,684,167 $61.4M No change
DNTH Dianthus Therapeutics Inc. 2.50% 1,744,373 $47.8M Reduce -16.7%
FDMT 4D Molecular Therapeutics Inc. 2.49% 4,400,000 $47.6M No change
MRUS Merus NV 2.38% 907,963 $45.4M Reduce -28.1%
ORIC Oric Pharmaceuticals Inc. 2.36% 4,394,527 $45.0M No change
ERAS Erasca Inc. 2.32% 16,216,216 $44.3M No change
PRAX Praxis Precision Medicines I 2.13% 706,131 $40.6M No change
ATXS Astria Therapeutics Inc. 1.99% 3,458,645 $38.1M Reduce -4.2%
TERN Terns Pharmaceuticals Inc. 1.49% 3,410,058 $28.4M No change
AQST Aquestive Therapeutics Inc. 1.45% 5,555,555 $27.7M No change
EWTX Edgewise Therapeutics Inc. 1.40% 1,000,000 $26.7M Reduce -45.0%
ARTV Artiva Biotherapeutics Inc. 1.30% 1,609,569 $24.9M New
ENGN Engene Holdings Inc. 1.23% 3,565,841 $23.5M Add +26.2%
CGEM Cullinan Therapeutics Inc. 1.21% 1,379,965 $23.1M No change
MERSANA THERAPEUTICS INC 1.12% 11,328,000 $21.4M No change
TSHA Taysha Gene Therapies Inc. 0.95% 9,000,000 $18.1M No change
ABVX Abivax SA-ADR 0.81% 1,345,780 $15.5M No change
TRVI Trevi Therapeutics Inc. 0.60% 3,422,656 $11.4M Add +0.0%
ARVN Arvinas Inc. 0.59% 454,450 $11.2M Reduce -27.6%
ADVM Adverum Biotechnologies Inc. 0.54% 1,467,048 $10.3M No change
IPSC Century Therapeutics Inc. 0.48% 5,389,259 $9.2M No change
ZURA Zura Bio Ltd. 0.43% 2,023,166 $8.2M Reduce -66.4%
FRNM Freenome Inc. filed as PERCEPTIVE CAP SOLUTIONS COR 0.39% 750,000 $7.5M No change
CABA Cabaletta Bio Inc. 0.39% 1,563,952 $7.4M No change
CASIF Casi Pharmaceuticals Inc. 0.32% 987,259 $6.1M Add +784.0%
TNYA Tenaya Therapeutics Inc. 0.16% 1,555,556 $3.0M No change
TIL Instil Bio Inc. 0.12% 33,177 $2.2M New
TENX Tenax Therapeutics Inc. 0.04% 208,333 $721K New

Portfolio Sells Q2 2024 → Q3 2024

MRUS Merus NV Reduce -28.1% 2.38% −2.38
DNTH Dianthus Therapeutics Inc. Reduce -16.7% 2.50% −0.95
ZURA Zura Bio Ltd. Reduce -66.4% 0.43% −0.91
EWTX Edgewise Therapeutics Inc. Reduce -45.0% 1.40% −0.69
ARVN Arvinas Inc. Reduce -27.6% 0.59% −0.48
ARCA BIOPHARMA INC Sold out 0.00% −0.21
ATXS Astria Therapeutics Inc. Reduce -4.2% 1.99% −0.10

Portfolio Buys Q2 2024 → Q3 2024

ORKA Oruka Therapeutics Inc. New 3.96% +3.96
APLT Applied Therapeutics Inc. Add +3.0% 4.37% +1.54
VRDN Viridian Therapeutics Inc. Add +0.0% 4.63% +1.41
ARTV Artiva Biotherapeutics Inc. New 1.30% +1.30
CASIF Casi Pharmaceuticals Inc. Add +784.0% 0.32% +0.28
TIL Instil Bio Inc. New 0.12% +0.12
TENX Tenax Therapeutics Inc. New 0.04% +0.04
TRVI Trevi Therapeutics Inc. Add +0.0% 0.60% −0.05
ENGN Engene Holdings Inc. Add +26.2% 1.23% −0.46

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 33$3.3BAPGE, ORKA, ERAS, SYRE, DNTH
Q1 2026 33$2.7BAPGE, ERAS, ORKA, SYRE, KALV
Q4 2025 27$2.0BAPGE, ORKA, VRDN, SYRE, KALV
Q3 2025 33$1.8BAPGE, MTSR, OCUL, CDTX, VRDN
Q2 2025 31$1.3BAPGE, OCUL, MTSR, ELVN, KALV
Q1 2025 37$1.2BAPGE, MTSR, OCUL, ELVN, KALV
Q4 2024 37$1.5BAPGE, OCUL, ELVN, PRAX, VRDN
Q3 2024 38$1.9BAPGE, OCUL, ELVN, VRDN, APLT
Q2 2024 35$1.6BAPGE, ELVN, FDMT, OCUL, DYN
Q1 2024 38$2.1BAPGE, FDMT, OCUL, SYRE, MRUS